Emerson Exchange 365
Search
Sign-In / Register
Site
Search
Sign-In/Register
Services
Products
Control & Safety Systems
Asset Management
Measurement Instrumentation
Valves, Actuators & Regulators
Fluid Control & Pneumatics
Electrical Components & Lighting
Welding, Assembly & Cleaning
IIoT & Digital Transformation
Industries
Chemical
Food and Beverage
Industrial Energy
Life Sciences
Oil & Gas
Power
Refining
Other Industries
Women in STEM
Events
Düsseldorf 2024
Immerse - Anaheim 2023
Grapevine 2022
Nashville 2019
San Antonio 2018
The Hague 2018
World
China
South Korea
Russia
More
Cancel
Industries
More
Life Sciences
Life Sciences Blog
Forums
Blog
Library/Resources
Members
Tags
More
Cancel
Create New Post
Comment or Question? Become a member of this Emerson Exchange 365 group. Click here to join.
Life Sciences Blog
239
posts
DeltaV Spectral PAT for Life Sciences Podcast
8 days ago
Activity
Tags
Subscribe by email
More
Cancel
By date
By view count
By comment count
Descending
Ascending
Real-World Implications of Spectral PAT for Life Sciences
Jim Cahill
There is a growing buzz around spectral process analytical technology (PAT) for the life sciences industry. Spectral PAT sounds really fancy. What is it, and how can it affect my company’s mission to produce treatments and cures that improve the quality of life for our patients? Let’s start with the basics. The ultimate value proposition of every life sciences manufacturer is to produce goods that dramatically improve…
20 Dec 2022
Leverage Life Sciences Software to Reduce Time to Market
Jim Cahill
The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However, while many life sciences teams have moved to electronic records software , many teams are still inadvertently creating data silos—both horizontally across business…
29 Nov 2022
Module Type Package Unlocks the Flexibility Driving Pharma Innovation
Jim Cahill
There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic , more facilities than ever are being “born digital.” Some of these born-digital facilities are the result of new organizations with entirely digital strategies, and others are biopharmaceutical organizations that have been around…
7 Nov 2022
Let your Personnel Lead you to the Adaptive Plant
Jim Cahill
On Monday at the Emerson Exchange Users’ Conference , Emerson’s Michalle Adkins and AbbVie’s Jeff Ziolkowski moderated a panel with Fujifilm’s Soren Skerris , Takeda’s Dr. Nina Schwalb , Eli Lilly’s James Weber , and Emerson’s Christian Berg . The experts shared the strategies they have employed and the lessons they’ve learned on their journey across the BioPhorum Digital Plant Maturity Model toward creating adaptive…
26 Oct 2022
Reduce Waste & Increase Efficiency in Clean-in-Place Processes
Jim Cahill
While the idea of adding costs to a food and beverage or pharmaceutical industry process like Clean-in-Place/Steam-in-Place (CIP/SIP) has not traditionally been an easy decision, in today’s industrial environment that has changed. With the retirement of experts, the lack of availability of workers, the increase in materials costs and narrowness of margins, the principal way for food and beverage and pharma companies to…
21 Oct 2022
Reduce Waste & Increase Efficiency in Clean-in-Place Processes
Jim Cahill
While the idea of adding costs to a food and beverage or pharmaceutical industry process like Clean-in-Place/Steam-in-Place (CIP/SIP) has not traditionally been an easy decision, in today’s industrial environment that has changed. With the retirement of experts, the lack of availability of workers, the increase in materials costs and narrowness of margins, the principal way for food and beverage and pharma companies to…
21 Oct 2022
New Challenges for Gas Analyzer Designers
Jim Cahill
Household waste, industrial emissions, and automobile exhaust are some of the pollutants that can contribute to climate change. They can also make you feel under the weather. In addition, these emissions contribute to the depletion of the Earth’s ozone layer. Due to the threat of these environmental issues, countries around the world have enacted strict legislation aimed at reducing emissions. In the U.S., the EPA…
14 Oct 2022
New Challenges for Gas Analyzer Designers
Jim Cahill
Household waste, industrial emissions, and automobile exhaust are some of the pollutants that can contribute to climate change. They can also make you feel under the weather. In addition, these emissions contribute to the depletion of the Earth’s ozone layer. Due to the threat of these environmental issues, countries around the world have enacted strict legislation aimed at reducing emissions. In the U.S., the EPA…
14 Oct 2022
Software Simplifies Technology Transfer
Jim Cahill
The life sciences marketplace is changing faster than nearly any other industry. Gone are the days when companies focus on a single treatment to drive their entire business. Today’s life sciences manufacturers are challenged to bring new treatments to the marketplace as quickly as possible—a trend that was magnified during the COVID-19 pandemic . As a result, innovation is key today. And innovation requires technologies…
7 Oct 2022
Manufacturing Solutions in Personalized Healthcare
Jim Cahill
In our Part 1 post, Manufacturing Challenges in Personalized Healthcare , Emerson’s Christian Berg explored the challenges biopharmaceutical manufacturers face in advancing personalized healthcare. In this final part, he describes some solutions and technologies which facilitate the pursuit of the adaptive plant, as defined by the BioPhorum Digital Plant Maturity Model , required to meet these challenges. Christian…
7 Sep 2022
Manufacturing Challenges in Personalized Healthcare
Jim Cahill
When we hear the phrase “personalized healthcare,” many of us think about the medicines and therapeutics focused on our specific needs that deliver treatments to dramatically improve or restore our health and extend our lives. In a Pharma Focus Asia webinar, Pursuing the Adaptive Plant to Enable Personalized Healthcare , Emerson’s Christian Berg provides a broader perspective of personalized healthcare and its challenges…
23 Aug 2022
BioPhorum’s Roadmap for Speed to Market with In-Line Monitoring and Real-Time Release
Jim Cahill
Traditional manufacturing practices have served the biopharmaceutical industry well for years, but times are changing and a need for speed to market in life sciences while reducing manufacturing costs is putting a focus on enabling real-time release (RTR). Technologies such as advanced process control (APC), predictive analytics, in-line monitoring (ILM), and real-time release testing (RTRT) are critical to the new strategies…
7 Jul 2022
BioPhorum Cell and Gene Therapy Personas and User Stories
Jim Cahill
Earlier I featured two recent BioPhorum publications in these posts: BioPhorum MES of the Future BioPhorum Cell and Gene Therapy Actors and Process Maps Today, I’ll highlight the third and final publication, CGT Personas and User Stories , from this release of publications. As with the other two, Emerson’s Sean Buckley was one of the primary authors, along with others from Cytiva, Dassault Systems, Novartis…
28 Jun 2022
Shorten the Equipment Validation Process to Bring Projects Online Faster
Jim Cahill
One of the key stages delaying and increasing costs in life sciences projects is equipment validation. In fact, it is one of the elements of project completion that project teams are most eager to compress because the value of every incremental improvement is so great. As Michalle Adkins explains in her recent article in Pharma Manufacturing , “Ultimately, the total cost and time of the full validation process can be…
20 Jun 2022
BioPhorum Cell and Gene Therapy Actors and Process Maps
Jim Cahill
A few weeks ago I highlighted one of the three new BioPhorum publications, MES of the Future Manifesto . Today, I’ll highlight a second one, CGT [cell & gene therapy] Actors and Process Maps . Emerson’s Sean Buckley was one of the authors along with co-authors from Roche, Takeda, and BioPhorum. Contributions were made during this Cell and Gene Therapy workstream from numerous biopharmaceutical manufacturers and software…
16 Jun 2022
Is the Biotech Industry Growing?
Jim Cahill
In the biotech realm, many struggle to find experienced and technically savvy providers who can provide unique solutions in control automation. As trends accelerate in the biopharmaceutical industry, manufacturers are looking for new and improved approaches to address industry challenges. What role does Emerson play? Explore Emerson’s Single-Use Technologies to learn how Emerson offers control systems that save…
31 May 2022
BioPhorum MES of the Future
Jim Cahill
We’ve highlighted the work of Emerson experts in the Biophorum Operations Group in several posts . Its mission: …is to create environments where the global biopharmaceutical industry can collaborate and accelerate its rate of progress, for the benefit of all. Emerson’s Sean Buckley alerted me to three recently published documents that he helped develop. These documents include: MES of the Future Manifesto CGT…
27 May 2022
Hygienic Pressure Measurement for Pharmaceutical and Bioprocess Applications
Jim Cahill
The tolerance for pharmaceutical and bioprocess manufacturing variations is relatively small to meet the quality requirements of finished medicines and therapeutics. In a Process Instrumentation article, How to ensure reliable pressure transmitter measurement in pharmaceutical applications , Emerson’s Brandon Haschke shares how “Advanced hygienic pressure transmitters can reduce downtime and operating costs thanks to…
13 May 2022
Overcoming Pharmaceutical and Biotech Manufacturing Challenges
Jim Cahill
Recently, the Pharma Manufacturing World Summit was held in Boston. The focus of the conference is to improve: … cost performance while maintaining quality and compliance in the midst of rapidly changing supply chain models among internal and external manufacturing… Emerson’s Christian Berg presented Are We There Yet? Tackling Manufacturing Challenges with the Digital Plant. Christian opened with the idea that tackling…
21 Apr 2022
Faster Tech Transfer Unlocks Speed to Market
Jim Cahill
The rapid development of the COVID-19 vaccine has created a dramatic shift in the way the public and life sciences organizations view the manufacturing of pharmaceuticals. In a recent Q&A with Pharma Manufacturing , Nathan Pettus , president of Emerson’s process systems and solutions business, shared how a move toward more flexibility and modularity in the industry is cutting tech transfer times to drive improved speed…
12 Apr 2022
Adaptable Landscape Components Facilitate Digital Transformation
Jim Cahill
The BioPhorum Operations Group (BPOG) established a digital plant maturity model (DPMM) for biopharmaceutical manufacturing to define stages of factory evolution “from simple paper-based plants through to the fully automated and integrated ‘adaptive plant’ of the future.” The model gives organizations a common tool for industry comparison and measurement of progress. It also provides a platform to facilitate collaboration…
21 Mar 2022
Remote Monitoring Lays the Foundation for Lights-Out Manufacturing
Jim Cahill
It isn’t news that the global pandemic upended the way we operate our plants. When social distancing trapped our most valuable personnel outside the facilities we rely on, it suddenly meant finding new ways to get critical work done. But the reality is, those changes would have been coming—albeit less quickly—even without the influence of COVID. Retirements and shortages of experienced workers have been thinning out…
4 Mar 2022
Improve Speed to Market with Closed-Loop Process Control using Spectral PAT
Jim Cahill
We have witnessed an incredible change the last few years in how life sciences manufacturers deliver treatments . Today’s focus is on fast results, and that means products patients rely on cannot sit on shelves for weeks or months waiting on quality validation. In a recent article in Pharmaceutical Processing World , Emerson’s Bob Lenich and Bruce Greenwald explored a strategy plants are using to digitally transform…
3 Feb 2022
Ultrasonic Welding Helps Ramp Up COVID Test Production
Jim Cahill
Demand for COVID test kits remain high and challenge manufacturers to maximize their production levels. In a Plastic News article (registration required), Automation suppliers help meet demand for COVID-19 testing kits , Emerson’s Vernon Murray , president of Branson assembly and welding technologies, highlighted the importance of welding technology in driving production efficiency. The article opens noting the production…
27 Jan 2022
Regulatory Requirements for Medical Devices Webinar
Jim Cahill
There is a new requirement for medical device companies selling into the European market, called the Medical Device Regulation, or MDR. This new regulation places a focus on the supply chain, meaning suppliers in the industry must have a good understanding of the new regulation in order to do business. Problems arise when the supplier fails to take the necessary steps to understand and implement MDR requirements. In this…
26 Jan 2022
<
>